Azome Therapeutics
Company

Azome Therapeutics

Biotechnology Research 2 employees
Employees
2

Azome Therapeutics Overview

Industry
Biotechnology Research
Employees
2
Founded
2023
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Azome Therapeutics

Azome Therapeutics is an early-stage drug discovery company focused on developing selective antagonists of the NLRP3 inflammasome, an inflammatory pathway critical to the development of a wide variety of diseases. Our lead candidate, AZM-152, is a RHAMM-derived antagonist that blocks a key upstream priming signal involved in the aberrant activation of the NLRP3 inflammatory cascade.

Azome Therapeutics Contact Details

People in AeroLeads
1

Azome Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Elliott A. Gruskin Phd Chief Executive Officer, Azome
View

Compare Similar Companies to Azome Therapeutics